Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Scuola Normale Superiore, Pisa, Italy.
Hum Vaccin Immunother. 2021 Jun 3;17(6):1681-1685. doi: 10.1080/21645515.2020.1833580. Epub 2021 Jan 26.
Infants are at risk of developing serious diseases as a consequence of pertussis infection. Thus, to protect newborns, many countries, including Italy, have introduced pertussis maternal immunization. However, despite the compelling evidence supporting Tdap vaccinations, the rates of coverage among Italian pregnant women have remained consistently very low. Numerous studies have shown that healthcare providers' recommendations are critical for achieving high maternal vaccination coverages. This study explores Italian gynecologists' knowledge, attitude and practices concerning pertussis maternal immunization. Between July 2018 and September 2018, we performed a national cross-sectional survey administered by e-mail using the mailing list of the Association of Italian Hospital Obstetricians and Gynecologists (AOGOI): the mailing list included more than 3500 members. A total of 451 respondents distributed throughout Italy completed the online survey. Overall, 275 (60.97%) respondents did not routinely recommend pertussis vaccination to pregnant women, mainly for suboptimal knowledge of the maternal pertussis vaccine, protocols, and guidelines: furthermore, 15.44% (69/447) of gynecologists were not aware of the pertussis vaccination program for pregnant women. Gynecologists working in the South or in the Islands of Italy were less aware about the need of administering Tdap in expectant mothers, suggesting that there is a potential risk of health inequalities based on differing levels of vaccine knowledge and recommendations across Italy. In order to enable healthcare professionals to provide accurate and timely information on pertussis immunization to pregnant women, targeted educational programs to improve gynecologists' knowledge on pertussis vaccination are needed.
婴儿由于百日咳感染而面临罹患严重疾病的风险。因此,为了保护新生儿,包括意大利在内的许多国家都已推出了百日咳母体免疫接种。然而,尽管有大量证据支持 Tdap 疫苗接种,但意大利孕妇的覆盖率一直非常低。许多研究表明,医疗保健提供者的建议对于实现高孕产妇疫苗接种覆盖率至关重要。本研究探讨了意大利妇科医生在百日咳母体免疫接种方面的知识、态度和实践。在 2018 年 7 月至 2018 年 9 月期间,我们通过电子邮件使用意大利医院妇产科医生协会(AOGOI)的邮件列表进行了一项全国性横断面调查:邮件列表包括 3500 多名成员。共有 451 名分布在意大利各地的受访者完成了在线调查。总体而言,275 名(60.97%)受访者没有定期向孕妇推荐百日咳疫苗接种,主要是因为对母体百日咳疫苗、方案和指南的了解不足:此外,15.44%(69/447)的妇科医生不知道针对孕妇的百日咳疫苗接种计划。在意大利南部或岛屿工作的妇科医生对在孕妇中接种 Tdap 的必要性认识不足,这表明基于意大利各地疫苗知识和推荐水平的不同,存在健康不平等的潜在风险。为了使医疗保健专业人员能够向孕妇提供关于百日咳免疫接种的准确和及时的信息,需要开展有针对性的教育计划,以提高妇科医生对百日咳疫苗接种的认识。